Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Amino Collective is an institutional venture capital firm founded in 2020, with offices in Berlin, Germany, and London, UK. The firm specializes in early-stage investments, particularly in the health and bio sectors. Amino Collective was established to support founders who challenge conventional thinking and pursue innovative ideas. The firm has quickly gained recognition for its commitment to high-impact investments.
Currently, Amino Collective manages a portfolio of 25 companies, focusing on pre-seed and seed rounds. The firm aims to make a select number of impactful investments each year, emphasizing areas such as AI-driven drug discovery, digital therapeutics, clinical trial platforms, and synthetic biology. This targeted approach allows Amino Collective to maintain a high level of engagement with its portfolio companies.
Notable milestones include the acquisition of portfolio company Allcyte by Recursion, showcasing the firm's ability to identify and support successful ventures. Amino Collective's LP base and fund size remain undisclosed, but its active presence in the European market positions it as a significant player in the venture capital landscape.
Amino Collective primarily invests in the health and bio sectors, concentrating on pre-seed and seed rounds. The firm targets innovative areas such as AI-driven drug discovery, digital therapeutics, clinical trial platforms, and synthetic biology. This focus allows Amino Collective to align its investment strategy with emerging trends in healthcare and biotechnology.
The firm seeks to back unconventional founders, particularly those who are scientists or scientists-turned-entrepreneurs. Amino Collective values entrepreneurs who challenge established norms in health and life sciences, aiming to support transformative ideas that can lead to significant advancements in these fields. The check sizes for investments typically range from $250,000 to $5 million, accommodating various stages of early development.
Geographically, Amino Collective operates primarily in Europe, with a strong emphasis on Germany and the United Kingdom. This regional focus enables the firm to tap into local innovation ecosystems while maintaining a global perspective on health and biotech advancements.
Amino Collective's portfolio includes a diverse range of companies within the health and bio sectors. Notable portfolio companies include:
This portfolio reflects Amino Collective's commitment to supporting innovative solutions in healthcare and biotechnology, with a particular emphasis on companies that leverage advanced technologies and scientific research.
Manuel Grossmann - Founding Partner. Manuel has extensive experience in venture capital and has been involved in multiple successful investments in the health and biotech sectors.
Jingkun Li - Head of Finance & Operations. Jingkun oversees the financial and operational aspects of the firm, ensuring efficient management of resources.
Felicitas Hagen - Head of Marketing & Comms. Felicitas is responsible for the firm's marketing strategies and communication efforts, enhancing the visibility of Amino Collective.
Dr. Nirmesh Patel - Investor. Nirmesh brings a strong background in healthcare and life sciences, contributing to the firm's investment decisions.
Conny Gerth - Executive Assistant. Conny supports the team with administrative tasks and coordination.
Eva Smorodina - Investment Team Fellow. Eva assists in evaluating potential investments and supporting portfolio companies.
Timon Schneider - Investment Team Fellow. Timon works alongside the investment team, focusing on sourcing and analyzing new opportunities.
To pitch to Amino Collective, founders should visit their website at aminocollective.com. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, and team background. The firm prefers clear and concise presentations that highlight the innovative aspects of the startup.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are encouraged, as they can enhance the chances of securing a meeting with the investment team.
Amino Collective has been actively investing in high-impact startups within the health and bio sectors. Recent notable portfolio companies include Allcyte, which was acquired by Recursion, and Lindus Health, a clinical trial platform. The firm continues to expand its portfolio, focusing on innovative solutions in healthcare.
As of 2023, Amino Collective remains committed to making a select number of impactful investments each year, emphasizing its strategy of supporting unconventional founders and scientists in the health and biotech fields.
What are Amino Collective's investment criteria?
Amino Collective focuses on early-stage investments in the health and bio sectors, specifically targeting pre-seed and seed rounds. The firm seeks to back unconventional founders, particularly those who are scientists or scientists-turned-entrepreneurs, and values innovative ideas that challenge established norms.
How can startups apply or pitch to Amino Collective?
Startups can pitch to Amino Collective through their website at aminocollective.com. It is recommended to include a clear overview of the business model, market opportunity, and the team’s background in the pitch deck.
What makes Amino Collective different from other venture capital firms?
Amino Collective distinguishes itself by focusing on high-impact investments in the health and bio sectors, specifically targeting unconventional founders who challenge conventional thinking. The firm emphasizes collaboration and community among its portfolio companies.
What is the geographic scope of Amino Collective's investments?
The firm primarily invests in Europe, with a strong focus on Germany and the United Kingdom. This regional emphasis allows Amino Collective to engage deeply with local innovation ecosystems.
What is the typical check size for investments?
Amino Collective typically invests between $250,000 and $5 million in its portfolio companies, accommodating various stages of early development.
What kind of post-investment involvement does Amino Collective have?
Amino Collective adds value to its portfolio companies by leveraging its network of experts in the health and biotech sectors, providing strategic guidance, and fostering collaboration among founders.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.